This is investment research, not personal financial advice.
The announcement gives a project budget, not a Tesla budget
Tesla shares closed 2.83% higher at $328.58 on 7 August, one day after SpaceX put a Texas location and a $16.8 billion first-phase estimate around the proposed Terafab semiconductor project. The move looks roughly proportionate to that limited information: location and scale became clearer, while Tesla's own funding obligation did not.
SpaceX says the first phase of Terafab, a proposed advanced-semiconductor complex in Grimes County, Texas, will require approximately $16.8 billion from SpaceX and Tesla. It also describes more than 100 million square feet of planned manufacturing space and a plant intended to combine logic, memory, advanced packaging and testing. Chips would serve Tesla products such as Optimus and Cybercab as well as SpaceX's planned space-based data centres (SpaceX 2026a). That industrial ambition can alter supply chains, but it is not yet a complete investment case for Tesla, Inc.
The absent number is Tesla's own commitment. At the 10 August research cutoff, no Tesla-specific project agreement or current report had disclosed how much cash or stock Tesla would contribute, when payments would fall due, which entity would own the fab, what capacity Tesla would receive, or how intellectual property and cost overruns would be allocated. SpaceX's earlier registration statement is unusually explicit about this incompleteness: it had a general framework with Tesla, but specific timelines, milestones and capital expenditure remained subject to separate negotiation; it also warned that neither Tesla nor Intel was obliged to remain (SpaceX 2026b). The public project website sets immense output ambitions, but not the missing economics (Terafab 2026).
That gap matters because Tesla is already in a capital-intensive turn. Its July quarterly filing raised expected 2026 capital expenditure to more than $25 billion, while first-half free cash flow was only $352 million before deducting $2.181 billion of stock-based compensation. The balance sheet can carry substantial investment. The current earnings stream has not demonstrated that it can earn the equity market's implied return on that investment.
Reaction verdict: roughly proportionate, with an important caveat. Friday's close was $328.58 after $319.53 on Thursday; 39.390 million shares traded, almost exactly the author-calculated 20-session average of 39.387 million. The session also contained a weak US employment release. The evidence supports “positive close, ordinary volume, mixed catalysts”, not a claim that the project alone added value.
What is proposed, what is filed, and what is still inference
Three documents describe different layers of the proposal.
- The August location announcement. SpaceX identifies Grimes County, estimates $16.8 billion of initial capital from SpaceX and Tesla, and says later phases could lift the total materially. “Estimated”, “planned” and “will be built” language describes intent; it does not disclose completed financing (SpaceX 2026a).
- The June securities filing. SpaceX's S-1/A defines Terafab as a chip-manufacturing initiative intended to produce one terawatt of compute hardware annually. It says the Tesla framework leaves projects, milestones, timelines and capital expenditure undetermined and may never produce definitive agreements (SpaceX 2026b).
- The project website. Terafab's own material illustrates a 100-million-square-foot footprint, one-terawatt annual output and applications spanning Tesla and SpaceX. Those are sponsor ambitions, not audited capacity, yield or return forecasts (Terafab 2026).
These documents establish a proposed joint industrial programme and a combined first-phase estimate. They do not establish Tesla's percentage. A simple boundary test shows why that is the central variable. If Tesla funded 10% of the initial phase, its contribution would be $1.68 billion; 25% would be $4.20 billion; 50% would be $8.40 billion; and the entire phase would be $16.80 billion. Those are author calculations, not scenarios attributed to either company. The all-Tesla boundary equals 38.6% of Tesla's $43.524 billion of cash, cash equivalents and short-term investments at 30 June. Even the 25% illustration exceeds Tesla's entire FY2025 free cash flow after stock-based compensation.
A semiconductor fab also creates obligations beyond the cheque written at groundbreaking. Clean-room equipment, process development, yield learning, utilities, water, chemical handling, working capital and recurring technology transitions can all absorb capital. The party that funds construction may not be the party that owns tools or process IP. A customer can receive reserved capacity without equity ownership; an owner can bear losses before saleable yields arrive. Until the definitive project agreement answers those questions, “vertical integration” identifies a strategic direction, not a measurable Tesla return.
There is a further disclosure nuance. SpaceX's S-1/A describes Terafab with Tesla and Intel, whereas the later update attributes initial capital to SpaceX and Tesla. That sequence supports careful wording: the currently announced sponsors intend to build, and an earlier filing contemplated another technical participant. It does not support assuming a fixed consortium or attributing a financing share to any participant.
Friday's gain did not settle the question
Tesla rose $9.05, or 2.83%, to $328.58 on 7 August. StockAnalysis records an intraday range of $321.25 to $333.73 and volume of 39,389,827 shares (StockAnalysis 2026). We calculated the 20-session mean directly from the same published history: 39,386,847. The ratio is 1.0001. A price increase on essentially normal volume is evidence of demand, but not evidence that investors collectively priced a known Tesla project return.
The macro tape supplies a second reason not to force a single-cause story. The US Bureau of Labor Statistics reported that July nonfarm payroll employment fell 23,000 and unemployment was 4.1%, both little changed in its characterisation (BLS 2026). The 10-year Treasury constant-maturity yield had been 4.69% on 6 August (FRED 2026). Weak labour data can affect rate expectations and the discount rates applied to long-duration equities. Terafab, macro news, positioning and company-specific expectations all shared the session.
The reaction is also small relative to the uncertainty. Friday's market-cap increase, using the same 3,949.547 million point-in-time shares, was approximately $35.7 billion. That change exceeds twice the announced first-phase project budget, but it cannot sensibly be labelled “Terafab value”: shares outstanding are a static author-calculation input, daily prices reflect all information, and no causal decomposition is available. The positive close is consistent with a non-negative reception, but it does not reveal what return investors expect from Tesla's unknown contribution.
Q2 and the first half: higher revenue, lower conversion
Tesla's latest filing presents a materially different operating baseline from a company merely adding one more factory. Q2 revenue grew, but operating income fell and capital spending accelerated sharply. The table separates reported Q2 and first-half figures from author-derived cash measures. All amounts are USD millions except per-share data and margins.
| Period | Revenue | Operating income | Operating margin | NPAT to common | Diluted EPS | OCF | Capex | FCF | SBC | FCF after SBC |
|---|---|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 28,236 | 398 | 1.4% | 1,114 | $0.32 | 4,697 | 5,789 | (1,092) | 1,151 | (2,243) |
| H1 FY2026 | 50,623 | 1,339 | 2.6% | 1,591 | $0.45 | 8,634 | 8,282 | 352 | 2,181 | (1,829) |
| H1 FY2025 comparator | 41,831 | 1,322 | 3.2% | 1,581 | $0.45 | 4,696 | 3,886 | 810 | 1,208 | (398) |
Method: operating margin equals operating income divided by revenue. Free cash flow, or FCF, equals operating cash flow less purchases of property and equipment excluding finance leases, net of sales. “FCF after SBC” further deducts stock-based compensation because issuing claims on owners is an economic cost even though accounting adds it back in operating cash flow. Standalone Q2 OCF, capex and SBC are author calculations subtracting Q1 from H1; Q1 reported $3.937 billion, $2.493 billion and $1.030 billion respectively (Tesla 2026a; Tesla 2026b). This is not Tesla's definition of owner earnings.
H1 revenue rose 21.0% year on year, while operating income rose only 1.3%. Capex increased 113.1%. The operating-cash-flow improvement included $3.341 billion of favourable movement in accounts payable, accrued and other liabilities. The cash-flow reconciliation separately reversed a $1.005 billion unrealised gain on Tesla's SpaceX equity investment out of NPAT, so the gain affected earnings quality but did not increase operating cash flow. Working capital can reverse; neither item is a permanent substitute for operating margin.
Q2's mix is informative. Automotive revenue was $20.516 billion, energy generation and storage $3.139 billion, and services and other $4.581 billion. They represented 72.7%, 11.1% and 16.2% of total revenue. Compared with Q2 FY2025, automotive grew 23.1%, energy 12.5% and services 50.4%. Consolidated operating income nevertheless fell 56.9%, to $398 million from $923 million. Revenue growth is therefore real; incremental operating conversion is not yet adequate.
Tesla ended June with $15.219 billion of cash and equivalents and $28.305 billion of short-term investments. Against $9.342 billion of debt and finance leases, author-calculated net cash was $34.182 billion. The company had $5 billion undrawn under its recourse revolving facility, while most balance-sheet debt was non-recourse automotive, China working-capital or energy financing. Liquidity can support construction; the return on that investment remains central.
Six years show the margin cycle that valuation must overcome
The annual record shows both Tesla's industrial achievement and the distance between peak economics and today's baseline. Values below are USD millions except EPS, shares and margins. FY2020-FY2022 values reflect Tesla's later split-adjusted per-share presentation. The annual filings are cross-checked across successive comparative statements (Tesla 2021; Tesla 2022; Tesla 2023; Tesla 2024; Tesla 2025; Tesla 2026c).
| Fiscal year | Revenue | Operating income | Operating margin | NPAT to common | Diluted EPS | OCF | Capex | FCF | SBC | FCF after SBC | Diluted shares m |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | 31,536 | 1,994 | 6.3% | 721 | $0.21 | 5,943 | 3,242 | 2,701 | 1,734 | 967 | 3,249 |
| 2021 | 53,823 | 6,523 | 12.1% | 5,519 | $1.63 | 11,497 | 6,482 | 5,015 | 2,121 | 2,894 | 3,386 |
| 2022 | 81,462 | 13,656 | 16.8% | 12,583 | $3.62 | 14,724 | 7,172 | 7,552 | 1,560 | 5,992 | 3,475 |
| 2023 | 96,773 | 8,891 | 9.2% | 14,997 | $4.30 | 13,256 | 8,899 | 4,357 | 1,812 | 2,545 | 3,485 |
| 2024 | 97,690 | 7,076 | 7.2% | 7,091 | $2.04 | 14,923 | 11,342 | 3,581 | 1,999 | 1,582 | 3,498 |
| 2025 | 94,827 | 4,355 | 4.6% | 3,794 | $1.08 | 14,747 | 8,527 | 6,220 | 2,825 | 3,395 | 3,528 |
| H1 2026, interim | 50,623 | 1,339 | 2.6% | 1,591 | $0.45 | 8,634 | 8,282 | 352 | 2,181 | (1,829) | 3,538 |
Revenue compounded at 24.6% from 2020 to 2025. Operating income compounded at only 16.9%, and that endpoint comparison masks a decline of 68.1% from the 2022 peak. Operating margin fell from 16.8% in 2022 to 4.6% in 2025 and 2.6% in H1 FY2026. FY2023 NPAT included a $5.9 billion tax valuation-allowance release, which helps explain why net income rose while operating income fell; it is not recurring automotive economics.
FCF looks steadier than operating income because working capital, capex timing and non-cash costs vary. After charging SBC, annual owner earnings peaked at $5.992 billion in FY2022, halved in FY2023 and were negative in the latest half. Diluted weighted-average shares rose from 3.249 billion in FY2020 to 3.538 billion in H1 FY2026, an 8.9% increase. Tesla reported about 3.949 billion common shares outstanding as of 16 July 2026, reflecting equity awards and acquisitions. Per-share economics therefore lag the operating aggregate.
For a trailing view, we combine FY2025 with H1 FY2026 and subtract H1 FY2025. The result is $103.619 billion revenue, $4.372 billion operating income, $3.804 billion NPAT, $18.685 billion OCF, $12.923 billion capex, $5.762 billion FCF and $1.964 billion after-SBC owner earnings. The trailing operating margin is 4.2%. This baseline is not a forecast, but it prevents a valuation from quietly using peak 2022 margins as if they were current.
Return on invested capital
Our author-computed ROIC proxy is 6.9%. We take trailing operating income of $4.372 billion, apply a 22% normalised tax rate to produce $3.410 billion of NOPAT, and divide by average invested capital of $49.565 billion. Invested capital is stockholders' equity plus debt and finance leases less cash and short-term investments: $46.454 billion at December 2025 and $52.676 billion at June 2026. This convention excludes noncontrolling interests and operating-lease capital, so another provider can reasonably produce a different answer.
The same convention produces author-computed FY2025 incremental ROIC of -112.2%. Normalised-tax NOPAT fell from $5.519 billion in FY2024 to $3.397 billion in FY2025, while invested capital rose from $44.563 billion to $46.454 billion. The calculation is ($3.397 billion minus $5.519 billion) divided by ($46.454 billion minus $44.563 billion). The small $1.891 billion denominator makes the percentage unstable, so its direction matters more than its precision: the latest full-year reinvestment interval coincided with lower operating profit.
For valuation we use a rounded 10% cost-of-capital assumption, not a company-reported measure. The assumption sits 5.31 percentage points above the 4.69% US 10-year Treasury yield observed on 6 August and is tested across 8.5%-13% in the scenario table. The useful conclusion does not depend on a second decimal place: recent returns are below that hurdle, and incremental investment has coincided with lower operating profit.
Automotive still funds the option set; energy improves the mix
Tesla is legally and economically one company, but its valuation narrative contains several businesses at different maturity levels.
Automotive. This remains the cash engine and the concentration. Tesla designs vehicles, powertrains, software and manufacturing systems, sells directly in many markets, and operates service and charging infrastructure. Vertical integration can reduce supplier margins and accelerate iteration. It also internalises fixed cost and execution risk. When pricing or utilisation weakens, depreciation, labour and factory overhead do not disappear. The fall in operating margin since 2022 is direct evidence that manufacturing scale does not guarantee stable unit economics.
Energy generation and storage. FY2025 energy revenue reached $12.771 billion and gross margin rose to 29.8% from 26.2%, helped by Megapack and Powerwall deployments and lower manufacturing costs, partly offset by tariffs (Tesla 2026c). This is strategically useful diversification: grid-storage demand has different purchase cycles from consumer vehicles, and software such as Autobidder can deepen customer integration. It is still only 11.1% of Q2 revenue, so it cannot yet offset a large automotive margin move.
Services and other. Q2 growth was rapid, but this bucket includes used vehicles, paid Supercharging, insurance, maintenance, parts and merchandise. It supports fleet retention and monetises infrastructure, yet it is not disclosed with stand-alone operating profit. Treating every service dollar as high-margin software would be an unsupported inference.
Autonomy, AI and robotics. Tesla has real inputs: a deployed fleet, camera data, in-house software, compute infrastructure and vehicle actuators. The economic output remains prospective. Supervised driver assistance is not the same product or liability profile as unsupervised paid mobility. Optimus demonstrations are not evidence of commercial gross margin. Our valuation gives these activities substantial upside in the bull case, but does not count sponsor ambition as current owner earnings.
Semiconductors. Terafab could secure specialised logic and memory, shorten design loops and reduce geopolitical supply exposure. Those are plausible strategic benefits. The counterweight is process complexity. Semiconductor yield, equipment access and node transitions are distinct capabilities from vehicle assembly. A captive fab is valuable only if its all-in cost, performance, reliability and utilisation compare favourably with foundry supply over a full cycle.
The moat is broad, but financial proof is uneven
| Moat source | Current state | Evidence and limitation |
|---|---|---|
| Integrated vehicle, software and manufacturing stack | Challenged, not gone | In-house engineering and rapid over-the-air updates shorten iteration. A 4.2% trailing operating margin shows the stack is not currently protecting peak economics. |
| Supercharger network and NACS | Durable infrastructure advantage | Tesla says all major automakers announced NACS adoption in certain markets. More users increase relevance, but expansion, uptime and congestion management require capital (Tesla 2026c). |
| Direct sales, service and installed fleet | Useful customer channel | Direct feedback and fleet connectivity support software deployment. Service capacity, residual values and repair quality can also transmit dissatisfaction directly to the brand. |
| Energy storage hardware plus controls | Strengthening | FY2025 energy gross margin of 29.8% and growing deployments provide a second profit pool. Revenue concentration remains automotive. |
| Battery, lithium and supply-chain integration | Strategic but capital heavy | Tesla began operations at its Texas lithium refinery in January 2026. Localisation can reduce input risk; owning more steps also concentrates execution and commodity-cycle exposure. |
| AI training, fleet data and robotics | Scarce inputs; monetisation unproven | Data, compute and actuators may improve products. Current accounts do not isolate durable autonomy or Optimus owner earnings. |
| Brand and mission | Valuable, volatile | Recognition lowers discovery costs and supports ecosystem demand. Brand strength is difficult to separate from product pricing, CEO visibility and political polarisation. |
The assets qualify as a moat only if they sustain returns above the cost of capital. Tesla's operations are unusually integrated and its installed network is difficult to reproduce quickly. The present ROIC evidence is below that economic threshold. For the moat thesis to strengthen, energy, autonomy or manufacturing efficiency must lift after-SBC cash returns without requiring proportionately more capital.
Competition and concentration shape Terafab's payoff
Tesla competes simultaneously with scale manufacturers, lower-cost electric-vehicle specialists, autonomy developers, battery suppliers and energy-system integrators. BYD exerts pressure through battery integration and broad price points; General Motors, Ford, Hyundai-Kia, Volkswagen and Toyota bring distribution, procurement and financing scale; Rivian and Lucid target narrower EV categories. In energy storage, Tesla faces battery manufacturers, integrators and utilities. In autonomy and ride services, Waymo and incumbent platforms establish a separate performance and regulatory benchmark.
General Motors illustrates why “legacy” is not synonymous with economically irrelevant. GM reported Q2 2026 EBIT-adjusted of $3.943 billion, including $3.446 billion from GM North America, despite recording substantial adjustments tied partly to EV capacity realignment (GM 2026). The comparison is not like-for-like: GM has combustion vehicles, a financing arm and different accounting. It does show that Tesla's $398 million quarterly operating income competes against peers able to fund product transitions from existing profits.
Three concentrations matter:
- Customer and product concentration. Tesla does not disclose a single dominant external customer in its latest filing, but automotive supplied 72.7% of Q2 revenue. Consumer affordability, financing rates, resale values and regional incentives therefore flow quickly into consolidated results.
- Supplier and geography concentration. Battery cells, semiconductors, raw materials and specialised equipment can be constrained or tariffed. Tesla manufactures across the US, China and Germany and sells globally, exposing costs and demand to trade policy, currencies and local regulation. Terafab may reduce chip-supply dependence eventually; during construction it adds exposure to lithography, tool and process suppliers.
- Capital concentration. Tesla is ramping vehicles, batteries, energy storage, AI compute, robotics, charging and now a semiconductor framework. Each can be rational alone. Together they compete for engineers, management attention and liquidity. Portfolio breadth becomes a weakness if governance cannot rank projects by risk-adjusted per-share return.
The Terafab thesis is strongest if Tesla would otherwise face a binding chip shortage, if captive silicon materially improves vehicle or robot economics, and if Tesla secures capacity without bearing a disproportionate construction risk. It is weakest if external foundries can supply comparable chips, demand arrives later than the fab, or the fab's learning curve absorbs cash while automotive margins remain thin.
Capital allocation is now the central governance test
The following table separates reported commitments from unknowns and author interpretation.
| Capital destination | Verified status at cutoff | Scale | Per-share question |
|---|---|---|---|
| Core factories, AI compute, data centres, R&D lines, fleet and charging | Company expects more than $25bn of 2026 capex | H1 spend already $8.282bn | Can operating cash flow cover the second-half run-rate without sacrificing maintenance or relying on working capital? |
| SpaceX equity investment | $2.002bn cash outflow in H1 2026; filing reversed a $1.005bn unrealised gain out of NPAT in the H1 OCF reconciliation | About 4.6% of June cash and short-term investments at cost | What strategic access and cash return compensate Tesla holders for related-party exposure? |
| Terafab | Combined initial phase estimated at $16.8bn; Tesla share and schedule unavailable | 10%/25%/50% illustrations equal $1.68bn/$4.20bn/$8.40bn | Does Tesla receive ownership, reserved capacity, pricing rights, board rights and IP proportionate to risk? |
| Employee and CEO equity | Share-based compensation $2.181bn in H1; period-end shares increased materially | H1 after-SBC FCF was negative $1.829bn | Can per-share cash generation outrun dilution? |
| Dividends and repurchases | Tesla says it has never paid a cash dividend, does not expect one in the foreseeable future, and reported no FY2025 issuer purchases | No recurring cash distribution | Retained capital must be judged against future returns, not payout support. |
The $25-billion-plus capex outlook supersedes the more-than-$20-billion expectation in Tesla's FY2025 annual report. It was disclosed before the August Terafab update, but the quarterly filing already included “semiconductor” operations among capital-intensive initiatives. Investors cannot tell whether Tesla's prospective Terafab share sits inside that outlook, replaces other projects, or would be incremental. That should be asked explicitly rather than assumed.
The balance sheet provides optionality. June net cash of $34.182 billion is substantial, and current assets of $68.758 billion exceeded current liabilities of $35.425 billion. Yet liquidity is a capacity to spend, not proof that spending creates value. At our rounded 10% cost-of-capital assumption, every additional $1 billion of durable invested capital needs roughly $100 million of annual after-tax operating profit merely to cover that hurdle. A $4.2 billion Terafab contribution, the 25% illustration, would need about $420 million. That is an author calculation before allowing for ramp risk or depreciation differences.
Related parties require process, not presumption
Elon Musk holds overlapping leadership roles across Tesla, SpaceX and xAI. Overlap can accelerate technical collaboration and reduce negotiation friction. It can also make transfer pricing, opportunity allocation, information boundaries and board independence more consequential. This is a governance condition, not evidence of misconduct.
Tesla's FY2025 filing says it periodically transacts with entities affiliated with its CEO and directors under its Related Person Transactions Policy. It recognised $430 million of revenue and $285 million of cost from xAI's Megapack purchases in 2025. It also disclosed a January 2026 agreement to invest about $2 billion in xAI Series E preferred shares after a fiduciary-duty and related-party-policy review. Following SpaceX's acquisition of xAI, Tesla's H1 cash-flow statement describes a $2.002 billion “SpaceX equity investment” (Tesla 2026a; Tesla 2026c). The accounting trail is observable; the long-term strategic return is not yet observable.
The 2025 proxy adds two capital-allocation signals. Stockholders were asked to replenish the general employee reserve by 60 million shares and to create a separate reserve for potential CEO awards; the award framework uses extremely large market-capitalisation and operating milestones (Tesla 2025 Proxy). High hurdles can align pay with outcomes, but share reserves still create dilution capacity and some performance definitions exclude stock-based compensation. For outside owners, the cleanest test is after-SBC value per share.
Terafab should therefore arrive with unusually clear safeguards: disinterested-board approval; independent valuation of contributions and received rights; explicit procurement pricing; audit rights; conflict procedures; milestone-based funding; termination rights; cost-overrun allocation; and disclosure of IP ownership. Shareholder approval may or may not be legally required depending on the eventual structure. No public document reviewed establishes that threshold. The correct position is “requirements unavailable”, not a prediction.
Macro, policy and regulatory exposure
A capital-intensive consumer manufacturer is sensitive to both ends of the yield curve. Higher rates raise vehicle payments and the discount rate applied to long-dated autonomy or robotics cash flows. A 4.69% 10-year Treasury rate leaves little room for equity valuations built on remote profits (FRED 2026). Weak employment can encourage lower-rate expectations, but it can also signal household demand risk. July's payroll decline therefore cuts both ways for Tesla (BLS 2026).
Trade and fiscal policy are similarly two-sided. Tariffs can protect domestic manufacturing and support the strategic case for a US fab, while increasing imported equipment, battery-material and component costs. Tesla's filings identify trade-policy changes, raw-material availability and tariff exposure as risks. Changes enacted in 2025 substantially curtailed US consumer EV incentives and tightened eligibility for clean-energy credits. Domestic production may earn policy support, but an investment case should not capitalise support that has not been awarded.
Vehicle regulation remains a separate economic risk. Tesla discloses extensive oversight, investigations, product-liability claims and evolving autonomous-driving rules. Software remedies can reduce physical recall cost, but they do not eliminate engineering, insurance, litigation or reputational exposure. This article does not use a circulated NHTSA campaign number because the specified report URL did not resolve during verification and its described subject could not be confirmed. A recall should never be characterised as a crash finding unless the regulator says so.
Semiconductor manufacturing brings additional permitting and environmental obligations. The SpaceX update discusses reservoir water, on-site wastewater treatment, hazardous materials and pollution control. These are plans and commitments, not evidence that permits have been issued or operating yields achieved (SpaceX 2026a). Water, electricity and local infrastructure are operating constraints as much as community issues.
Valuation: the existing accounts explain little of $328.58
The market price at writing was $328.58. Using the 3,949.547 million shares Tesla reported as outstanding on 16 July 2026, the author-calculated market capitalisation was $1,297,742 million, or $1.297742 trillion. StockAnalysis independently rounded its 10 August pre-market capitalisation snapshot to $1.30 trillion (StockAnalysis Statistics 2026). Subtracting $34.182 billion of net cash gives enterprise value of $1,263.560 billion. The share input is a point-in-time count, whereas income metrics use weighted-average shares; this distinction is disclosed to prevent false precision.
Against trailing figures, the market pays:
- 341.2 times trailing NPAT of $3.804 billion;
- 225.2 times trailing FCF of $5.762 billion;
- 660.8 times trailing after-SBC owner earnings of $1.964 billion; and
- 289.0 times trailing operating income on an enterprise-value basis.
These multiples are author calculations, not comparables adjusted for Tesla's different businesses. They say the market price is not anchored to current automotive-led cash generation. It is capitalising a large transition to higher earnings from autonomy, robotics, energy, software and perhaps semiconductors.
Earnings-power cross-check
A no-growth earnings-power value is intentionally severe. Capitalising trailing after-SBC owner earnings of $1.964 billion at 10% and adding net cash produces $13.63 per share. Replacing the depressed trailing amount with an author-normalised $8 billion produces $28.91. Neither estimate assigns growth or option value, so neither is a complete Tesla valuation. Their purpose is to show how little of $328.58 comes from a steady-state reading of the existing accounts.
Four-case owner-earnings DCF
We value equity directly from after-SBC owner earnings. Each case starts with an explicit, normalised year-zero amount rather than automatically extrapolating H1's negative figure. We grow owner earnings for years 1-5 at the first rate and years 6-10 at the second, discount each annual flow, calculate a Gordon-growth terminal value at year 10, and add $34.182 billion of net cash. Values are divided by 3,949.547 million shares. All ranges are sensitivity bands, not price targets or management guidance.
| Case | Starting owner earnings | Years 1-5 growth | Years 6-10 growth | Discount rate | Terminal growth | Value per share |
|---|---|---|---|---|---|---|
| Severe | $2bn-$3bn | 0%-5% | 0%-3% | 12%-13% | 2.0% | $12.79-$17.64 |
| Bear | $4bn-$6bn | 10%-15% | 5%-7% | 11%-12% | 2.5% | $24.51-$43.45 |
| Base | $8bn-$12bn | 20%-25% | 8%-10% | 9.5%-10.5% | 3.0% | $73.48-$156.99 |
| Bull | $15bn-$20bn | 28%-35% | 12%-15% | 8.5%-9.5% | 3.5%-4.0% | $244.18-$616.83 |
The scenario bands move several inputs together. The table below isolates the two dominant variables, starting after-SBC owner earnings and growth over years 1-5. Years 6-10 growth is fixed at 8%, the discount rate at 10%, terminal growth at 4%, net cash at $34.182 billion and shares at 3,949.547 million.
| Starting owner earnings | 10% growth | 20% growth | 30% growth | 40% growth |
|---|---|---|---|---|
| $6bn | $47.47 | $66.82 | $93.51 | $129.48 |
| $10bn | $73.34 | $105.60 | $150.08 | $210.03 |
| $15bn | $105.68 | $154.07 | $220.79 | $310.72 |
| $20bn | $138.02 | $202.54 | $291.51 | $411.41 |
This controlled sensitivity shows why starting cash power and the first five years of compounding dominate the result. At the fixed assumptions above, even $15 billion of starting owner earnings with 40% annual growth reaches only $310.72 per share. Crossing Friday's close requires a starting base near the top of the bull case and growth close to the table's upper edge.
Friday's $328.58 close is above the base range and appears only inside the bull range. The bull low already assumes starting owner earnings roughly eight times the trailing $1.964 billion, then 28% annual growth for five years. The bull high combines a $20 billion starting base, 35% first-stage growth and an 8.5% discount rate. It is possible only if several option businesses become large and cash generative while capital intensity moderates.
The reverse DCF makes the same point without selecting a value range. Start from $8 billion of after-SBC owner earnings, assume 10% growth in years 6-10, a 10% discount rate and 4% terminal growth. Solving for the first five years to reach $328.58 requires 59.0% annual growth. That takes owner earnings to roughly $81.2 billion in year five before the second-stage growth begins. The calculation is not a prediction. It is the performance encoded by that particular set of assumptions.
Terafab enters this model through cash flow, not by adding the announced $16.8 billion to value. A Tesla contribution reduces near-term owner earnings or net cash. Value appears only if the resulting chips increase later cash earnings through lower cost, superior performance, capacity security or new product revenue. Counting both the expenditure as an “asset” and the hoped-for product profit without a return charge would double count.
Scenario logic and the path between them
Severe: industrial overreach. Automotive pricing remains competitive, operating margin stays below 5%, autonomy and robotics do not produce material external cash flow, and Terafab adds fixed cost before utilisation. Net cash absorbs setbacks but after-SBC owner earnings remain $2 billion-$3 billion. This case does not require insolvency; it requires only that Tesla remain a low-return manufacturer with ambitious projects.
Bear: partial recovery, expensive option set. Vehicle and energy volume grow, operating margin recovers modestly, and some software revenue appears. Capital remains elevated and dilution continues. Terafab secures useful capacity but does not earn a premium return. Owner earnings begin at $4 billion-$6 billion and grow, leaving valuation dominated by a terminal recovery that still falls far below the current equity price.
Base: strong execution without category domination. Energy keeps attractive gross margin, manufacturing efficiency improves, autonomy generates meaningful recurring economics in selected markets, and capex growth slows after the current build. Starting owner earnings of $8 billion-$12 billion already require a large improvement from trailing results. Twenty to 25% first-stage growth then produces a substantial business, but the $73-$157 range remains below Friday's close because the entry valuation is exceptionally demanding.
Bull: multiple platforms work. Tesla achieves high utilisation across vehicles and energy, turns autonomy and Optimus into large cash-generating products, and uses proprietary silicon to improve both cost and performance. Terafab reaches competitive yields without disproportionate overruns. Share dilution is controlled and owner earnings start at $15 billion-$20 billion before compounding 28%-35%. This is the only case that brackets the market price, and its lower end still does not fully support it.
The scenarios should not be probability-weighted mechanically while the funding agreement is absent. Assigning a precise Terafab probability and a precise Tesla share would create spurious accuracy. The decision-relevant information is which operational facts move the company from one case to another.
The crux, monitoring thresholds and what changes the view
Advanced chips matter, but the investment turns on Tesla receiving a return-bearing claim proportionate to the cash, execution risk and dilution it contributes. Its core and energy businesses must also generate enough after-SBC cash to fund the wider programme.
Five thresholds would make that judgement less speculative:
- Definitive Terafab economics. A Tesla filing should quantify the maximum commitment, timing, funding instrument, ownership, governance, capacity rights, pricing, IP and overrun allocation. A disclosed Tesla share below $2 billion with strong capacity and termination rights would be qualitatively different from an open-ended multi-billion-dollar equity obligation.
- After-SBC owner earnings above $8 billion trailing. This is the low end of our base starting assumption and roughly four times the latest trailing level. It must come from recurring operations rather than investment marks or payables growth.
- Operating margin of at least 8%. That would not restore the 2022 peak, but it would show that revenue growth is again converting into operating profit. Below 5%, large factory programmes remain difficult to justify economically.
- Capex covered by OCF for two consecutive quarters. Coverage should occur without obvious deferral of maintenance, product delay or supplier stretch. H1 coverage was only 1.04 times before SBC and other investing outflows.
- Per-share discipline. Year-on-year share growth below 2%, with clear disclosure around CEO, employee and acquisition issuance, would show that enterprise growth is reaching each share.
The catalyst timeline is tied to filings rather than an assumed construction calendar:
| Decisive fact | Resolution mechanism | First decision window |
|---|---|---|
| Tesla's Terafab commitment and rights | Definitive agreement, Tesla 8-K or quarterly filing; SpaceX amendment if the arrangement is material there | No announced deadline; inspect every filing cycle beginning with Tesla's Q3 FY2026 report |
| Recovery in after-SBC owner earnings and operating margin | Tesla quarterly accounts and cash-flow statements | Q3 FY2026 through Q1 FY2027 provides three consecutive tests |
| Capex coverage and funding capacity | Two consecutive quarterly OCF and capex disclosures | Earliest confirmation is Q4 FY2026 after Q3 and Q4 data are available |
| Dilution and related-party safeguards | FY2026 10-K, 2027 proxy and any transaction-specific filing | First full annual test in early 2027; earlier if a new award or agreement is filed |
What would change the cautious interpretation? A project agreement with capped Tesla funding, independently reviewed terms, preferential capacity and auditable IP rights would reduce governance and cash uncertainty. Evidence that Tesla-designed chips lower system cost enough to lift consolidated return on capital above WACC would turn vertical integration into financial proof. Sustained energy margins above 25%, autonomy revenue with disclosed economics, and an after-SBC cash inflection would justify moving assumptions toward the bull range.
What would make it more adverse? Open-ended cost sharing, unclear ownership, equity issuance to fund the fab, repeated capex-outlook increases, operating margin below 3%, or related-party approvals without quantified fairness analysis would all push the scenario set downward. So would a rising share count that absorbs operating improvement.
Source notes and confidence
Confidence is high in issuer identity, reported financial history, Friday's close, SpaceX's combined $16.8 billion estimate and the fact that the public documents leave Tesla's specific Terafab obligation unresolved. Tesla, Inc. and TSLA were checked against the SEC ticker registry (SEC 2026). Annual and quarterly figures were read from SEC filings; market history was independently fetched; macro figures came from BLS and FRED.
Confidence is medium in the project's eventual scale and timing because sponsor materials describe an ambition and site plan, while the earlier securities filing says definitive terms may not be reached. The model values are fully reproducible author calculations but highly sensitive to starting owner earnings, growth, discount rate and terminal assumptions.
Missing or unavailable at cutoff: Tesla's project agreement; Tesla's funding percentage and schedule; construction milestones; ownership and governance rights; process node, wafer-start capacity and commercial yield targets; customer pricing; IP allocation; permit status; and a Tesla-specific current report for the August announcement. The supplied Tesla X status URL returned unavailable during this run, so it is not used to substantiate financing. A circulated NHTSA PDF URL also failed and the claimed campaign description was not independently verified, so it is omitted rather than guessed.
The market-cap calculation uses the 7 August close and the exact share count reported as of 16 July, not the incomplete 10 August session. Q2 cash flow is derived by subtracting the Q1 filing from H1. FCF, FCF after SBC, net cash, ROIC, multiples, DCF values and all percentage comparisons are author calculations. Numbers may differ from data-vendor metrics because conventions differ; no model output is company guidance.
References
- (SpaceX 2026a) SpaceX, Breaking Ground on Terafab in Texas, 6 August 2026. Official project-location and initial-capital announcement.
- (SpaceX 2026b) Space Exploration Technologies Corp., Form S-1/A, 3 June 2026. SEC-filed framework description and Terafab risk factors.
- (Terafab 2026) Terafab, Project overview, accessed 10 August 2026. Sponsor description of proposed scale, output and use cases.
- (Tesla 2026a) Tesla, Inc., Form 10-Q for the quarter ended 30 June 2026, filed 23 July 2026. Q2/H1 accounts, liquidity, capex and risk disclosures.
- (Tesla 2026b) Tesla, Inc., Form 10-Q for the quarter ended 31 March 2026, filed 23 April 2026. Q1 cash-flow inputs used in standalone Q2 calculations.
- (Tesla 2026c) Tesla, Inc., Form 10-K for the year ended 31 December 2025, filed 29 January 2026. FY2025 accounts, strategy, related parties and capital allocation.
- (Tesla 2025) Tesla, Inc., Form 10-K for the year ended 31 December 2024, filed 29 January 2025. FY2024 accounts and comparative history.
- (Tesla 2024) Tesla, Inc., Form 10-K for the year ended 31 December 2023, filed 29 January 2024. FY2023 accounts and comparative history.
- (Tesla 2023) Tesla, Inc., Form 10-K for the year ended 31 December 2022, filed 31 January 2023. FY2022 accounts and comparative history.
- (Tesla 2022) Tesla, Inc., Form 10-K for the year ended 31 December 2021, filed 7 February 2022. FY2021 accounts and comparative history.
- (Tesla 2021) Tesla, Inc., Form 10-K for the year ended 31 December 2020, filed 8 February 2021. FY2020 accounts and comparative history.
- (SEC 2026) US Securities and Exchange Commission, Company ticker registry, accessed 10 August 2026. Tesla, Inc. issuer identity and TSLA mapping.
- (StockAnalysis 2026) StockAnalysis, Tesla stock price history, data through 7 August 2026. Close, previous close, range and volume history.
- (StockAnalysis Statistics 2026) StockAnalysis, Tesla market statistics, accessed before the 10 August 2026 open. Rounded market capitalisation cross-check.
- (GM 2026) General Motors, Q2 2026 earnings release, 21 July 2026. Peer revenue, operating income, margin and cash-flow context.
- (BLS 2026) US Bureau of Labor Statistics, The Employment Situation — July 2026, 7 August 2026. Payroll and unemployment data.
- (FRED 2026) Federal Reserve Bank of St. Louis, 10-Year Treasury Constant Maturity Rate (DGS10), data through 6 August 2026. Rate context.
- (Tesla 2025 Proxy) Tesla, Inc., 2025 definitive proxy statement, filed 17 September 2025. Equity reserves, CEO award design and governance disclosures.